Nyt fra tidsskrifterne
Søgeord (remdesivir) valgt.
18 emner vises.
1
Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 Seropositivity
Clinical Infectious Diseases
Tilføjet 29.04.2025
2
Case series of patients with laboratory confirmed Marburg virus disease, 2023 Equatorial Guinea
Clinical Infectious Diseases
Tilføjet 26.04.2025
3
A systemic approach to estimate and validate RP-HPLC assay method for remdesivir and favipiravir in capsule dosage form
PLoS One Infectious Diseases
Tilføjet 16.04.2025
4
Remdesivir associated with reduced mortality in hospitalized COVID-19 patients: treatment effectiveness using real-world data and natural language processing
BMC Infectious Diseases
Tilføjet 12.04.2025
5
Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis
Journal of Medical Virology
Tilføjet 21.03.2025
6
SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy
BMC Infectious Diseases
Tilføjet 14.03.2025
7
A systematic review and meta-analysis of the effectiveness of remdesivir to treat SARS-CoV-2 infection in hospitalized patients: have the guidelines evolved with the evidence?
Clinical Infectious Diseases
Tilføjet 12.03.2025
8
COVID‐19 Patients Benefitting From Remdesivir for Improved Survival: A Neural Network‐Based Approach
Journal of Medical Virology
Tilføjet 11.03.2025
9
Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
BMC Infectious Diseases
Tilføjet 6.02.2025
10
Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection
PLoS One Infectious Diseases
Tilføjet 6.02.2025
11
The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023–2024 phase of JN.1 subvariant dominance
BMC Infectious Diseases
Tilføjet 30.01.2025
12
Real-world evidence of remdesivir in formerly hospitalized COVID-19 patients: patient-reported and functional outcomes
BMC Infectious Diseases
Tilføjet 12.01.2025
13
SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants
Antimicrobial Agents And Chemotherapy
Tilføjet 20.12.2024
14
Evidence that remdesivir treatment reduces viral titers in patients with COVID-19
Antimicrobial Agents And Chemotherapy
Tilføjet 8.11.2024
15
Reply to Boyd et al., “Evidence that remdesivir treatment reduces viral titers in patients with COVID-19”
Antimicrobial Agents And Chemotherapy
Tilføjet 8.11.2024
16
Public Health Benefits of Applying Evidence-Based Best Practices in Managing Patients Hospitalized for COVID-19
Clinical Infectious Diseases
Tilføjet 26.10.2024
17
Remdesivir for Patients Hospitalized with COVID-19: Evidence of Effectiveness from Cohort Studies in the Omicron Era
Clinical Infectious Diseases
Tilføjet 25.10.2024
18
Management of vulnerable patients hospitalized for COVID-19 with remdesivir: a retrospective comparative effectiveness study of mortality in US hospitals
Clinical Infectious Diseases
Tilføjet 19.10.2024